Article

Messenger RNA (mRNA) therapeutics have evolved from COVID-19 vaccines to a versatile platform for encoding therapeutic proteins, gene regulation, and genome editing. This article delves into the scientific basis, delivery systems, applications, challenges, manufacturing, and ethical implications of mRNA technologies, highlighting its transformative potential in diverse medical fields.

The development of 3D organoids and organ-on-chip technologies has transformed preclinical research by mimicking human tissue in vitro. These advanced models enhance understanding of human biology and diseases while improving drug development and personalized medicine. Challenges remain in standardization, validation, and ethical considerations as these tools advance biomedical research.

The article discusses the human microbiome’s crucial role in health and disease, emphasizing the potential of microbiome engineering and live biotherapeutics. It explores ecological principles, engineering strategies, clinical applications for various disorders, and future directions such as personalized therapeutics and digital biology. The need for innovation and regulatory frameworks is highlighted.

Artificial Intelligence is transforming drug discovery by reducing development timelines and costs while improving success rates. Advanced AI techniques, like machine learning and generative models, streamline processes from target identification to clinical trials. This evolution prompts discussions around data quality, regulatory challenges, and ethical implications, shaping the future of medicine.